[New active drugs against the tuberculosis bacillus and other mycobacteria].
D000583:Amikacin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D007769:Lactams; D009161:Mycobacterium / Q000187:drug effects*; D009162:Mycobacterium avium / Q000187:drug effects*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D009170:Nontuberculous Mycobacteria / Q000187:drug effects*; D012293:Rifampin / Q000031:analogs & derivatives; D014376:Tuberculosis / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D007769:Lactams; D009268:Nalidixic Acid; D000583:Amikacin; D012293:Rifampin
Nuevas drogas activas contra el bacilo tuberculoso y otras micobacterias.